How to buy Fennec Pharmaceuticals stock | $7.72

Fennec Pharmaceuticals Inc is a biotechnology business based in the US. Fennec Pharmaceuticals shares (FENC) are listed on the NASDAQ and all prices are listed in US Dollars. Fennec Pharmaceuticals employs 4 staff and has a market cap (total outstanding shares value) of USD$179.8 million.

How to buy shares in Fennec Pharmaceuticals

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Fennec Pharmaceuticals. Find the stock by name or ticker symbol: FENC. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Fennec Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$7.72, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Fennec Pharmaceuticals, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Fennec Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Fennec Pharmaceuticals share price

Use our graph to track the performance of FENC stocks over time.

Fennec Pharmaceuticals shares at a glance

• Key figures

Information last updated 2020-12-26.

Latest market close	USD$7.72
52-week range	USD$4.6501 - USD$9.75
50-day moving average	USD$7.7999
200-day moving average	USD$7.4974
Wall St. target price	USD$15
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.669

Buy Fennec Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Fennec Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Fennec Pharmaceuticals Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Fennec Pharmaceuticals price performance over time

Historical closes compared with the close of $7.72 from 2020-12-09

1 week (2021-01-11)	5.18%
1 month (2020-12-18)	3.21%
3 months (2020-10-16)	1.31%
6 months (2020-07-17)	-17.34%

1 year (2020-01-17)	24.92%
2 years (2019-01-18)	10.60%
3 years (2018-01-18)	9.4001
5 years (2016-01-15)	582.64%

Fennec Pharmaceuticals financials

Gross profit TTM	USD$0
Return on assets TTM	-45.5%
Return on equity TTM	-80.03%
Profit margin	0%
Book value	$1.208
Market capitalisation	USD$179.8 million

TTM: trailing 12 months

Shorting Fennec Pharmaceuticals shares

There are currently 1.2 million Fennec Pharmaceuticals shares held short by investors – that's known as Fennec Pharmaceuticals's "short interest". This figure is 4.8% down from 1.3 million last month.

There are a few different ways that this level of interest in shorting Fennec Pharmaceuticals shares can be evaluated.

Fennec Pharmaceuticals's "short interest ratio" (SIR)

Fennec Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Fennec Pharmaceuticals shares currently shorted divided by the average quantity of Fennec Pharmaceuticals shares traded daily (recently around 127018.10526316). Fennec Pharmaceuticals's SIR currently stands at 9.5. In other words for every 100,000 Fennec Pharmaceuticals shares traded daily on the market, roughly 9500 shares are currently held short.

However Fennec Pharmaceuticals's short interest can also be evaluated against the total number of Fennec Pharmaceuticals shares, or, against the total number of tradable Fennec Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Fennec Pharmaceuticals's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Fennec Pharmaceuticals shares in existence, roughly 40 shares are currently held short) or 0.0594% of the tradable shares (for every 100,000 tradable Fennec Pharmaceuticals shares, roughly 59 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Fennec Pharmaceuticals.

Find out more about how you can short Fennec Pharmaceuticals stock.

Fennec Pharmaceuticals share dividends

We're not expecting Fennec Pharmaceuticals to pay a dividend over the next 12 months.

Have Fennec Pharmaceuticals's shares ever split?

Fennec Pharmaceuticals's shares were split on a 1:3 basis on 5 September 2014. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Fennec Pharmaceuticals shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Fennec Pharmaceuticals shares which in turn could have impacted Fennec Pharmaceuticals's share price.

Fennec Pharmaceuticals share price volatility

Over the last 12 months, Fennec Pharmaceuticals's shares have ranged in value from as little as $4.6501 up to $9.75. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fennec Pharmaceuticals's is 0.0047. This would suggest that Fennec Pharmaceuticals's shares are less volatile than average (for this exchange).

Fennec Pharmaceuticals overview

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina.

Frequently asked questions

• What percentage of Fennec Pharmaceuticals is owned by insiders or institutions?

  Currently 16.829% of Fennec Pharmaceuticals shares are held by insiders and 54.285% by institutions.

• How many people work for Fennec Pharmaceuticals?

  Latest data suggests 4 work at Fennec Pharmaceuticals.

• When does the fiscal year end for Fennec Pharmaceuticals?

  Fennec Pharmaceuticals's fiscal year ends in December.

• Where is Fennec Pharmaceuticals based?

  Fennec Pharmaceuticals's address is: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709

• What is Fennec Pharmaceuticals's ISIN number?

  Fennec Pharmaceuticals's international securities identification number is: CA31447P1009

• What is Fennec Pharmaceuticals's CUSIP number?

  Fennec Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00686R101